DD209972A5 - Verfahren zur herstellung eines topischen, entzuendungshemmenden mittels - Google Patents

Verfahren zur herstellung eines topischen, entzuendungshemmenden mittels Download PDF

Info

Publication number
DD209972A5
DD209972A5 DD83252997A DD25299783A DD209972A5 DD 209972 A5 DD209972 A5 DD 209972A5 DD 83252997 A DD83252997 A DD 83252997A DD 25299783 A DD25299783 A DD 25299783A DD 209972 A5 DD209972 A5 DD 209972A5
Authority
DD
German Democratic Republic
Prior art keywords
piroxicam
agent
weight
carbon atoms
item
Prior art date
Application number
DD83252997A
Other languages
German (de)
English (en)
Inventor
Katsumi Ohya
Toshiji Kawazoe
Shigenori Nozawa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14821545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD209972(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of DD209972A5 publication Critical patent/DD209972A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DD83252997A 1982-07-13 1983-07-12 Verfahren zur herstellung eines topischen, entzuendungshemmenden mittels DD209972A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57121853A JPS5913714A (ja) 1982-07-13 1982-07-13 外用消炎鎮痛剤

Publications (1)

Publication Number Publication Date
DD209972A5 true DD209972A5 (de) 1984-05-30

Family

ID=14821545

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83252997A DD209972A5 (de) 1982-07-13 1983-07-12 Verfahren zur herstellung eines topischen, entzuendungshemmenden mittels

Country Status (27)

Country Link
US (1) US4678666A (da)
EP (1) EP0101178B2 (da)
JP (1) JPS5913714A (da)
KR (1) KR860001801B1 (da)
AR (1) AR230375A1 (da)
AU (1) AU543654B2 (da)
CA (1) CA1206418A (da)
CS (1) CS241062B2 (da)
DD (1) DD209972A5 (da)
DE (1) DE3373270D1 (da)
DK (1) DK159640C (da)
EG (1) EG17670A (da)
ES (1) ES524094A0 (da)
FI (1) FI78235C (da)
GR (1) GR78874B (da)
HK (1) HK85289A (da)
HU (1) HU187110B (da)
IE (1) IE54844B1 (da)
IL (1) IL69207A0 (da)
IN (1) IN159679B (da)
NO (1) NO162494C (da)
NZ (1) NZ204870A (da)
PH (1) PH18117A (da)
PL (1) PL147503B1 (da)
PT (1) PT77016B (da)
SG (1) SG30489G (da)
ZA (1) ZA835058B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6168413A (ja) * 1984-09-10 1986-04-08 Lion Corp 外用ゲル組成物
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4654169A (en) * 1985-02-06 1987-03-31 Givaudan Corporation Phenyl-aliphatic oximes as odorants
JPS61212516A (ja) * 1985-03-18 1986-09-20 Toyobo Co Ltd ピロキシカム軟膏剤
JPH0794394B2 (ja) * 1986-12-24 1995-10-11 前田薬品工業株式会社 消炎鎮痛外用貼付剤
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5599768A (en) * 1989-09-21 1997-02-04 E. I. Du Pont De Nemours And Company Stabilization of non-aqueous suspensions
US4988500A (en) * 1989-09-29 1991-01-29 The Procter & Gamble Company Oral compositions
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
ATE95421T1 (de) * 1990-04-26 1993-10-15 Sagitta Arzneimittel Gmbh Piroxicam enthaltende pharmazeutische zusammensetzung zur topischen anwendung.
FR2679135B1 (fr) * 1991-07-18 1995-05-19 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
HU209518B (en) * 1992-12-23 1994-06-28 Egyt Gyogyszervegyeszeti Gyar Process for production of free of skin damaging effect unguent preparation containing piroxicam
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
ES2074030B1 (es) * 1994-01-31 1996-02-01 S A L V A T Lab Sa Composiciones portadoras, autocalentadoras y aplicables en terapeutica por via topica.
US5905092A (en) * 1994-09-27 1999-05-18 Virotex Corporation Reel/Frame Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
GB2305603A (en) * 1995-09-26 1997-04-16 Allied Medical Group Topical cooling gels for reducing excess body fat
KR100288190B1 (ko) * 1998-02-09 2001-04-16 김용규 피록시캄 함유 알콜성 하이드로겔 조성물
KR100342945B1 (ko) * 1999-03-09 2002-07-02 민경윤 항진균제의 외용 약제 조성물 및 이의 제조방법
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
KR100406576B1 (ko) * 2001-06-23 2003-11-20 최후균 경피투여용 패취제
US20060067958A1 (en) * 2004-09-24 2006-03-30 Unilab Pharmatech, Ltd. Pharmaceutical topical gel compositions
JP2006188500A (ja) * 2004-12-08 2006-07-20 Toyama Chem Co Ltd ピロキシカムを含有する外用液剤
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド 炎症のための治療用組成物およびその治療方法
KR20210133821A (ko) 2020-04-29 2021-11-08 신신제약 주식회사 피록시캄을 함유하는 경피 흡수 제제
WO2022251876A1 (en) * 2021-05-28 2022-12-01 Veterinary Pharmacy Corporation Water soluble complex compositions and methods thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541584A (en) 1968-08-14 1970-11-17 Bendix Corp Control for fog simulator effects
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
JPS5381616A (en) * 1976-12-27 1978-07-19 Kowa Co Production of antiinflammatory and anodyne ointment
JPS5540604A (en) 1978-09-14 1980-03-22 Mitsui Toatsu Chem Inc Improved local topicum
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts

Also Published As

Publication number Publication date
DE3373270D1 (en) 1987-10-08
US4678666A (en) 1987-07-07
FI78235C (fi) 1989-07-10
DK320583A (da) 1984-01-14
DK159640B (da) 1990-11-12
NO162494C (no) 1990-01-10
AU543654B2 (en) 1985-04-26
PL147503B1 (en) 1989-06-30
IL69207A0 (en) 1983-11-30
FI78235B (fi) 1989-03-31
AR230375A1 (es) 1984-04-30
IE831611L (en) 1984-01-13
AU1676783A (en) 1984-01-19
CS241062B2 (en) 1986-03-13
PT77016B (en) 1986-05-05
ZA835058B (en) 1984-03-28
ES8500738A1 (es) 1984-11-01
HU187110B (en) 1985-11-28
PH18117A (en) 1985-03-22
ES524094A0 (es) 1984-11-01
JPS5913714A (ja) 1984-01-24
DK159640C (da) 1991-04-08
IN159679B (da) 1987-05-30
KR860001801B1 (ko) 1986-10-23
PL242971A1 (en) 1985-05-21
PT77016A (en) 1983-08-01
HK85289A (en) 1989-11-03
FI832536L (fi) 1984-01-14
FI832536A0 (fi) 1983-07-12
EP0101178A3 (en) 1985-05-22
EP0101178B1 (en) 1987-09-02
EP0101178A2 (en) 1984-02-22
NO162494B (no) 1989-10-02
CA1206418A (en) 1986-06-24
CS528283A2 (en) 1985-07-16
GR78874B (da) 1984-10-02
JPH0338250B2 (da) 1991-06-10
SG30489G (en) 1989-08-11
IE54844B1 (en) 1990-02-28
NO832529L (no) 1984-01-16
DK320583D0 (da) 1983-07-12
NZ204870A (en) 1986-06-11
KR840005340A (ko) 1984-11-12
EP0101178B2 (en) 1992-08-12
EG17670A (en) 1991-03-30

Similar Documents

Publication Publication Date Title
DD209972A5 (de) Verfahren zur herstellung eines topischen, entzuendungshemmenden mittels
DE69523745T2 (de) Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut
DE69715049T2 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
DE69421685T2 (de) Entzündunghemmendes und analgetisches transdermales Gel enthaltend Ketoprofen
DE2839793C2 (de) Pharmazeutische Zubereitung zur äußeren Anwendung
KR950008305B1 (ko) 2상 용매 담체 조성물
DE2605242A1 (de) Entzuendungshemmendes arzneimittel zur oertlichen verwendung
CH638402A5 (de) Verfahren zur herstellung eines pharmazeutikums fuer die einfuehrung in koerperoeffnungen.
DE19549421C2 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE60204620T2 (de) Nasenspray enthaltend Ondansetronhydrochlorid
DD266506A5 (de) Verfahren zur herstellung einer pharmazeutischen band-zusammensetzung
CH662274A5 (de) Pharmazeutische creme vom oel-in-wasser-typ.
US4440778A (en) Anti-inflammatory analgesic cataplasm and process for producing the same
DE69302396T2 (de) Antiviral wirksame pharmazeutische öl in wasser-emulsion, die 9-[(2-hydroxyethoxy)methyl]-guanin (acyclovir) oder ein salz oder einen ester davon enthält
DE2601489A1 (de) Tretinoin enthaltende gelpraeparate
DE19541919C2 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE60307086T2 (de) Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx
DE60104442T2 (de) Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen
CH699814B1 (de) Diclofenac zur topischen Anwendung als Spray.
DE2515594C3 (de) Verfahren zur Herstellung eines stabilen, topisch aktiven Geles
EP1196159B1 (de) Verwendung von tosylchloramid(en) zur behandlung von erkrankungen der haut, der schleimhaut, von organen und geweben
EP0450123A1 (de) Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung
DE2410939A1 (de) Lokalanaesthetisches mittel
EP3213745B1 (de) Galenische zubereitung von nsaid
TR2021018637A2 (tr) Uzun etki̇li̇ lokal anestezi̇k krem, jel ve sprey formülasyonu

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)